2010
DOI: 10.1016/j.biocel.2010.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Colon carcinogenesis: Learning from NF-κB and AP-1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
65
0
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(66 citation statements)
references
References 28 publications
0
65
0
1
Order By: Relevance
“…Since no additional inhibitory effects of [6]-gingerol were seen in combination with the inhibitors of ERK1/2 or JNK, we believe that no other additional factors up-regulated by PMA in SW-480 cells are affected by [6]-gingerol. Stimulation of MEK-ERK1/2 pathway by growth factors and induction of both ERK1/2 and JNK pathways by oncogenic proteins like Src and Ras, leading to the activation of their downstream targets, like AP-1, have been found crucial in the development of colon cancer [45], [46]. Inhibition of the constituents of MAP kinase pathway has long been recognized as ideal approach to arrest the progression of colon cancer [46].There are reports on other natural compounds like epicatechin gallate, curcumin, silibinin and red ginseng of inducing apoptosis in colon cancer cells via inhibition of MAP kinases [15], [47], [48], [49].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Since no additional inhibitory effects of [6]-gingerol were seen in combination with the inhibitors of ERK1/2 or JNK, we believe that no other additional factors up-regulated by PMA in SW-480 cells are affected by [6]-gingerol. Stimulation of MEK-ERK1/2 pathway by growth factors and induction of both ERK1/2 and JNK pathways by oncogenic proteins like Src and Ras, leading to the activation of their downstream targets, like AP-1, have been found crucial in the development of colon cancer [45], [46]. Inhibition of the constituents of MAP kinase pathway has long been recognized as ideal approach to arrest the progression of colon cancer [46].There are reports on other natural compounds like epicatechin gallate, curcumin, silibinin and red ginseng of inducing apoptosis in colon cancer cells via inhibition of MAP kinases [15], [47], [48], [49].…”
Section: Discussionmentioning
confidence: 99%
“…Stimulation of MEK-ERK1/2 pathway by growth factors and induction of both ERK1/2 and JNK pathways by oncogenic proteins like Src and Ras, leading to the activation of their downstream targets, like AP-1, have been found crucial in the development of colon cancer [45], [46]. Inhibition of the constituents of MAP kinase pathway has long been recognized as ideal approach to arrest the progression of colon cancer [46].There are reports on other natural compounds like epicatechin gallate, curcumin, silibinin and red ginseng of inducing apoptosis in colon cancer cells via inhibition of MAP kinases [15], [47], [48], [49]. [6]-gingerol was previously shown to inhibit the phosphorylation of ERK1/2, JNK and p38 MAP kinases in mouse skin cancer cell lines, hepatocarcinoma cells and pancreatic cancer cells [28], [34], [36], [50].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has also been demonstrated that NF-κB plays an important role in the control of cell proliferation, survival and invasion as well as angiogenesis 32) . We previously demonstrated that the activation of NF-κB p65 is a process mediated by multiple receptors, although the activation of NF-κB p65 by LPS and anti-β2GPI/β2GPI is primarily mediated by TLR4 8) .…”
Section: Discussionmentioning
confidence: 99%
“…Members of the activating protein 1 (AP-1) and nuclear factor-B (NF-B) families of transcription factors control many essential physiological and pathological processes including inflammation, immune responses, host-defense, and cancer (for review, see Ghosh and Hayden, 2008;Peng, 2008;Vaiopoulos et al, 2010). Because these transcription factors are key regulators of the inducible expression of many proinflammatory mediators, their inhibition by small-molecule compounds represents an area of interest for new drug de-velopment.…”
Section: Introductionmentioning
confidence: 99%